THISX vs. SHPAX
THISX (T. Rowe Price Health Sciences Fund Class I) and SHPAX (Saratoga Health & Biotechnology Fund) are both Health & Biotech Equities funds. Over the past 5 years, THISX returned 6.39%/yr vs 5.59%/yr for SHPAX. Their correlation of 0.81 means they have usually moved in the same direction. THISX charges 0.67%/yr vs 2.90%/yr for SHPAX.
Performance
THISX vs. SHPAX - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with THISX having a 7.43% return and SHPAX slightly higher at 7.52%.
THISX
- 1D
- -1.20%
- 1M
- -2.44%
- 6M
- 7.79%
- YTD
- 7.43%
- 1Y
- 31.89%
- 3Y*
- 15.01%
- 5Y*
- 6.39%
- 10Y*
- —
- ALL TIME*
- 14.08%
SHPAX
- 1D
- -1.08%
- 1M
- -0.48%
- 6M
- 4.72%
- YTD
- 7.52%
- 1Y
- 27.56%
- 3Y*
- 9.41%
- 5Y*
- 5.59%
- 10Y*
- 6.81%
- ALL TIME*
- 6.54%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $0.00 | $0.00 | $0.00 | |
| $0.00 | $0.00 | $0.00 |
THISX vs. SHPAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
THISX T. Rowe Price Health Sciences Fund Class I | 7.43% | 17.92% | 16.75% | 3.17% | -12.11% | 13.62% | 30.35% | 38.29% | 1.20% | 26.96% |
SHPAX Saratoga Health & Biotechnology Fund | 7.52% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -5.30% | 11.78% |
Correlation
The correlation between THISX and SHPAX is 0.80, meaning they have usually moved in the same direction, including during past declines.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.80 |
Correlation (3Y) Balances recent behavior with more history. | 0.78 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.81 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2017 | 0.81 |
The correlation between THISX and SHPAX has been stable across timeframes, ranging from 0.78 to 0.81 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
THISX vs. SHPAX — Risk / Return Rank
THISX
SHPAX
THISX vs. SHPAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund Class I (THISX) and Saratoga Health & Biotechnology Fund (SHPAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| THISX | SHPAX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.03 | ||
| Sortino ratioReturn per unit of downside risk | +0.04 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.33 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 2.52 | 3.06 | -0.54 |
| Martin ratioReturn relative to average drawdown | 7.04 | 7.83 | -0.80 |
Loading charts...
Drawdowns
THISX vs. SHPAX - Drawdown Comparison
The maximum THISX drawdown since its inception was -28.97%, smaller than the maximum SHPAX drawdown of -69.50%. Use the drawdown chart below to compare losses from any high point for THISX and SHPAX.
Loading charts...
Drawdown Indicators
| THISX | SHPAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.97% | -69.50% | +40.53% |
Max Drawdown (1Y)Largest decline over 1 year | -12.78% | -9.33% | -3.45% |
Max Drawdown (3Y)Largest decline over 3 years | -15.80% | -16.32% | +0.52% |
Max Drawdown (5Y)Largest decline over 5 years | -27.53% | -16.32% | -11.21% |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.05% | — |
Current DrawdownCurrent decline from peak | -3.39% | -2.26% | -1.13% |
Average DrawdownAverage peak-to-trough decline | -7.10% | -27.77% | +20.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.57% | 3.63% | +0.94% |
Volatility
THISX vs. SHPAX - Volatility Comparison
The current volatility for T. Rowe Price Health Sciences Fund Class I (THISX) is 5.29%, while Saratoga Health & Biotechnology Fund (SHPAX) has a volatility of 5.69%. This indicates that THISX experiences smaller price fluctuations and is considered to be less risky than SHPAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| THISX | SHPAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.29% | 5.69% | -0.40% |
Volatility (6M)Calculated over the trailing 6-month period | 13.02% | 11.39% | +1.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.40% | 14.97% | +1.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.64% | 14.53% | +4.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.95% | 16.66% | +3.29% |
THISX vs. SHPAX - Expense Ratio Comparison
THISX has a 0.67% expense ratio, which is lower than SHPAX's 2.90% expense ratio.
Dividends
THISX vs. SHPAX - Dividend Comparison
THISX's dividend yield for the trailing twelve months is around 11.41%, more than SHPAX's 3.41% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | 3.41% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
THISX T. Rowe Price Health Sciences Fund Class I | 11.41% | 12.25% | 26.10% | 5.20% | 1.76% | 7.62% | 7.25% | 12.58% | 6.70% | 7.55% | 0.00% | 0.00% |
Frequently Asked Questions
THISX and SHPAX have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SHPAX has higher volatility (5.69%) compared to THISX (5.29%). In terms of maximum drawdown, THISX dropped -28.97% vs SHPAX's -69.50%.
THISX currently has the higher Sharpe Ratio (1.97 vs 1.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for THISX and SHPAX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer